Yüklüyor......
Specific CDK4/6 inhibition in breast cancer: a systematic review of current clinical evidence
BACKGROUND: Loss of cell cycle control is a hallmark of cancer, and aberrations in the cyclin-dependent kinase-retinoblastoma (CDK-Rb) pathway are common in breast cancer (BC). Consequently, inhibition of this pathway is an attractive therapeutic strategy. The present review addresses efficacy and t...
Kaydedildi:
| Yayımlandı: | ESMO Open |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
ESMO Open
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5419212/ https://ncbi.nlm.nih.gov/pubmed/28848657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000093 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|